适体市场按类型、应用、最终用户和地区划分

2025 年全球适体市场规模预计为 86 亿美元，预计到 2032 年将达到 274.2 亿美元，2025 年至 2032 年的复合年增长率为 18.0%。

数字。 2025 年适体市场占有率（按地区）

适体是与特定目标分子结合的单链去氧核糖核酸（DNA）或核糖核酸（RNA）分子。适体可以透过化学合成，以高亲和性和特异性识别和结合蛋白质、小分子和细胞表面标靶分子。与抗体相比，适体具有体积小、易于生产和修饰、无免疫抗原性、组织穿透性高等优点。适体被广泛应用于研究、诊断和治疗等领域。

市场动态

全球适体市场的成长受到生命科学和製药业不断增加的研发投入的推动。此外，由于其优势，适体越来越多地被用作诊断和研究中抗体的替代品，从而推动了市场的成长。然而，开发和生产适体的高成本是阻碍市场成长的主要因素。新技术的出现使得适体的生产变得更容易、更经济，为市场相关人员提供了重大机会。

研究的主要特点

• 本报告对全球适体市场进行了详细分析，并展示了预测期（2025-2032）的市场规模（十亿美元）和年复合成长率（CAGR%），以 2024 年为基准年。
• 它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
• 报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，涵盖了全球适体市场主要企业的概况。
• 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球适体市场满足该行业的各个相关人员的需求，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 透过分析全球适体市场所使用的各种策略矩阵，相关人员将发现决策更加容易。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 製造商收益
• 收购和合作场景
• 产品发布/核准
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球适体市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球适体市场类型（十亿美元）

• 介绍
• 核酸
• 胜肽适体

6. 2020 年至 2032 年全球适体市场应用情形（单位：十亿美元）

• 介绍
• 诊断
• 治疗
• 研究与开发

7. 2020-2032 年全球适体市场（以最终用户划分）（十亿美元）

• 介绍
• 生物科技和製药公司
• 学术研究所
• 合约研究组织

8. 2020 年至 2032 年全球适体市场（按地区划分）（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争格局

• 公司简介
  • AstraZeneca
  • Achiko AG
  • Agilent Technologies, Inc.
  • Amsbio
  • Aptagen LLC
  • Aptamer Group
  • CAGE Bio Inc.
  • GC Biopharma Corp.
  • GlyTech, Inc.
  • IVERIC bio, Inc.
  • NeoNeuro SAS
  • Novartis AG
  • Ophthotech Corporation
  • SomaLogic Operating Co., Inc.
  • TAGCyx BIoTechnologies Inc.
  • Vivonics Inc.
  • Zentek Ltd.

第 10 章分析师建议

• 兴衰
• 一致的机会地图

第 11 章 参考文献与调查方法

• 参考
• 调查方法

Global Aptamers Market is estimated to be valued at USD 8.60 Bn in 2025 and is expected to reach USD 27.42 Bn by 2032, growing at a compound annual growth rate (CAGR) of 18.0% from 2025 to 2032.

Figure. Aptamers Market Share (%), By Region 2025

Aptamers are single stranded Deoxyribonucleic acid (DNA) or Ribonucleic acid (RNA) molecules that bind to a specific target molecule. These can be chemically synthesized to recognize and bind protein, small molecule or cell surface targets with high affinity and specificity. Aptamers have several advantages over antibodies such as small size, easy production and modification, lack of immunogenicity and better tissue penetration. These have wide applications in research, diagnostics, therapeutics and others.

Market Dynamics:

Global aptamers market growth is driven by rising research and development investments in life sciences and pharmaceutical industries. Growing use of aptamers as an alternative to antibodies in diagnostics and research due to their advantages is also boosting the market growth. However, high costs associated with aptamer development and production is a major factor hampering the market growth. Emergence of novel technologies for simpler and cost-effective production of aptamers provides a significant opportunity for market players.

Key Features of the Study:

• This report provides in-depth analysis of the global aptamers market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global aptamers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study AstraZeneca, Achiko AG, Agilent Technologies, Inc., Amsbio, Aptagen LLC, Aptamer Group, CAGE Bio Inc., GC Biopharma Corp., GlyTech, Inc., IVERIC bio, Inc., NeoNeuro SAS, Novartis AG, Ophthotech Corporation, SomaLogic Operating Co., Inc., TAGCyx Biotechnologies Inc., Vivonics Inc., Zentek Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global aptamers market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aptamers market.

Detailed Segmentation-

• By Type:
  • Nucleic Acid
  • DNA-based Aptamers
  • RNA-based Aptamers
  • XNA-based Aptamers
  • Peptide Aptamers
• By Application:
  • Diagnostics
  • Therapeutics
  • Research and Development
• By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutions
  • Contract Research Organization
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AstraZeneca
  • Achiko AG
  • Agilent Technologies, Inc.
  • Amsbio
  • Aptagen LLC,
  • Aptamer Sciences, Inc.
  • CAGE Bio Inc.
  • GC Biopharma Corp.
  • GlyTech, Inc.
  • IVERIC bio, Inc.
  • NeoNeuro SAS
  • Novartis AG
  • Ophthotech Corporation
  • SomaLogic Operating Co., Inc.
  • TAGCyx Biotechnologies Inc.
  • Vivonics Inc.
  • Zentek Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Aptamers Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Aptamers Market, By Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Nucleic Acid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • DNA-based Aptamers
  • RNA-based Aptamers
  • XNA-based Aptamers
• Peptide Aptamers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Aptamers Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Therapeutics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research and Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Aptamers Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Biotechnology and Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutions
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organization
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Aptamers Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Achiko AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Agilent Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Amsbio
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Aptagen LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Aptamer Group
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • CAGE Bio Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • GC Biopharma Corp.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • GlyTech, Inc.
  • IVERIC bio, Inc.
  • NeoNeuro SAS
  • Novartis AG
  • Ophthotech Corporation
  • SomaLogic Operating Co., Inc.
  • TAGCyx Biotechnologies Inc.
  • Vivonics Inc.
  • Zentek Ltd.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"